Bayesian Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,931	Closed	-$1.23M	–	1123
2024 Q1	$1.23M	Buy	+2,931	New	+$1.24M	0.12%	245
2023 Q2	–	Sell	-9,131	Closed	-$2.88M	–	1082
2023 Q1	$2.88M	Buy	+9,131	New	+$2.74M	0.36%	74
2022 Q3	–	Sell	-1,831	Closed	-$516K	–	1039
2022 Q2	$516K	Sell	1,831 -7,869	-81%	-$2.11M	0.1%	327
2022 Q1	$2.53M	Buy	9,700 +6,560	+209%	+$1.56M	0.38%	41
2021 Q4	$690K	Buy	+3,140	New	+$611K	0.22%	136
2021 Q1	–	Sell	-6,100	Closed	-$1.44M	–	704
2020 Q4	$1.44M	Sell	6,100 -5,222	-46%	-$1.2M	0.38%	66
2020 Q3	$3.08M	Buy	+11,322	New	+$3.12M	0.75%	17
2020 Q1	–	Sell	-5,800	Closed	-$1.27M	–	997
2019 Q4	$1.27M	Buy	5,800 +4,308	+289%	+$872K	0.22%	139
2019 Q3	$253K	Buy	+1,492	New	+$264K	0.05%	402
2018 Q3	–	Sell	-16,421	Closed	-$2.79M	–	812
2018 Q2	$2.79M	Buy	16,421 +13,839	+536%	+$2.15M	0.63%	24
2018 Q1	$421K	Buy	+2,582	New	+$422K	0.11%	307
2017 Q1	–	Sell	-9,253	Closed	-$682K	–	708
2016 Q4	$682K	Buy	+9,253	New	+$753K	0.17%	230